Skip to content

Common Stock at other companies

AngioDynamics logo
AngioDynamicsANGO
$387K+0.5%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
200M0.0%
Delcath Systems logo
Delcath SystemsDCTH
80M0.0%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$22K-8.3%
LQD
Liquidia CorporationLQDA
$88K+3.5%
United Therapeutics logo
United TherapeuticsUTHR
$800K0.0%

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%
Debt / equity2.6×
Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s common stock?
TriSalus Life Sciences, Inc. (TLSI) reported common stock of 400M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s common stock changed year-over-year?
TriSalus Life Sciences, Inc.'s common stock decreased by 0.0% year-over-year, from 400M to 400M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).